Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/55358
Title: Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
Authors: 
Filiation: Servicio de Oncología Médica. Hospital Universitario de Fuenlabrada.
Keywords: 
Mesh: 
Decs: 
Issue Date: 6-Jun-2022
Publisher: Springer Science and Business Media LLC
Citation: Cánovas MS, Garay DF, Moran LO, Pérez JR, Rubio CMG, de Mena ML, Portero BO, Castro JB, Lage Y, Lavin DC, Blanco ABR, de Soignie AMMF, Perejón JZB, Colomo LJ, Boluda NB, Moreno JB, Verduguez TQ, Garrido CR, Huertas RM, Puig CFI, Martín AJM. Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group. Clin Transl Oncol. 2022 Oct;24(10):2010-2020. doi: 10.1007/s12094-022-02860-5. Epub 2022 Jun 6. PMID: 35668339; PMCID: PMC9418291.
Abstract: Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of information regarding patients in routine clinical practice.
PMID: 35668339
URI: https://hdl.handle.net/20.500.12530/55358
Rights: info:eu-repo/semantics/openAccess
Atribución-NoComercial-CompartirIgual 3.0 España
ISSN: 1699-048X
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
s12094-022-02860-5.pdf717.41 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons